21046 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof Lyases (4)
Proteoglycan degrading mutants for treatment of CNS
#302Materials and methods for modulating immune responses
#303USE OF COMPOSITIONS HAVING A LOW POLYAMINE CONTENT IN THE PREVENTION OR TREATMENT OF ADVERSE EFFECTS LINKED TO CANCER TREATMENT
#304CROSSLINKABLE TREHALOSE FOR THE COVALENT INCORPORATION IN HYDROGELS AND METHODS OF USE
#305Use of photolyase for reducing or improving subclinical field cancerization associated with actinic keratosis
#306Methods of treating and preventing social communication disorder in patients by intranasal administration of insulin
#307COMPOSITIONS AND METHODS FOR THE TREATMENT OF CNS INJURIES
#308Skeletal muscle regeneration promoter
#309Compositions and Methods for Treating Injuries to the Visual System of a Human
#310Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria
#311USE OF PLP WITH PEG-rMETase IN VIVO FOR ENHANCED EFFICACY
#312Methods of reducing extravasation of inflammatory cells
#313Cosmetic treatment system and methods
#314METHOD OF INDUCING IMMUNE TOLERANCE COMPRISING ADMINISTERING CARBONIC ANHYDRASE I
#315Flexible tissue matrix and methods for joint repair
#316Methods and kits for assessing heparanase procoagulant activity, compositions comprising heparanase, and methods for the treatment of coagulation related disorders
#317METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASES
#318Pharmaceutical composition for treating depression and method for preparation thereof
#319Enzyme prodrug cancer therapy selectively targeted to tumor vasculature and methods of production and use thereof
#320ALGINATE MICROPARTICLES AND METHODS OF USING THE SAME
#321Compositions and methods for treating or preventing oxalate-related disease
#322Controlling Pseudomonas aeruginosa persister cells with GM-CSF
#323Materials and methods for nerve grafting
#324Method for using an enzyme resistant to high pressures
#325COMPOSITION FOR PREVENTING OR TREATING OBESITY
#326USE OF PROKARYOTIC SPHINGOSINE-1-PHOSPHATE LYASES AND OF SPHINGOSINE-1-PHOSPHATE LYASES LACKING A TRANSMEMBRANE DOMAIN FOR TREATING HYPERPROLIFERATIVE AND OTHER DISEASES
#327Enzyme combinations to reduce brain tissue swelling
#328Agent for neuropathic pain
#329Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes
#330Bacteriophage-containing therapeutic agents
#331Acellular bioabsorbable tissue regeneration matrices
#332Methods and compositions for treating oxalate-related conditions
#333USE OF CARBONIC ANHYDRASE II FOR PRODUCING A DRUG
#334Methods of treating Parkinson's disease using viral vectors
#335AGENT FOR REDUCING ACETALDEHYDE IN ORAL CAVITY
#336COMPOSITIONS OF PROKARYOTIC PHENYLALANINE AMMONIA-LYASE VARIANTS AND METHODS OF USING COMPOSITIONS THEREOF
#337USE OF ISLET GLUCOSE-6-PHOSPHATASE RELATED PROTEIN AS A DIAGNOSTIC TOOL AND THERAPEUTIC TARGET FOR AUTOIMMUNE DIABETES
#338METHIONINE GAMMA LYASE-2-AMINOBUTYRATE DEAMINASE (MEGL-2ABD) AND THERAPEUTIC USES THEREOF
#339Compositions and methods of using chondroitinase ABCI mutants
#340Crystallized oxalate decarboxylase and methods of use
#341METHOD OF TREATING OR RETARDING THE DEVELOPMENT OF BLINDNESS
#342CARBONIC ANHYDRASE I SERVING AS NOVEL ANTIGEN TO BE USED FOR TREATMENT OF AUTOIMMUNE DISEASES
#343Compositions and methods for promoting neuronal outgrowth
#344Endorphin Therapy Compositions and Methods of Use Thereof
#345Bacteriophage-containing therapeutic agents
#346Sensitizing agents for cancer therapy, methods of use and methods for the identification thereof
#347Novel Glutamic Acid Decarboxylase (GAD) Chimera And Methods Of Use
#348MODIFIED HEPARINASE III AND METHODS OF SEQUENCING THEREWITH
#349Novel therapy for anxiety
#350IMPROVING AGENT FOR NEUROPATHIC PAIN
#351Formulations of 5-fluorocytosine and uses thereof
#352Methods of reducing extravasation of inflammatory cells
#353PROTEOGLYCAN DEGRADING MUTANTS FOR TREATMENT OF CNS
#354Cosmetic Methods And Compositions For Repairing Human Skin
#355GLUTAMIC ACID DECARBOXYLASE (GAD) BASED DELIVERY SYSTEM
#356MAMMALIAN HYPOTHALAMIC NUTRIENT MODULATION OF GLUCOSE METABOLISM
#357Methods and compositions for treating phenylketonuria
#358Composition for eliciting a specific CTL response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells
#359Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growrh factors of stem cells
#360Materials and methods for nerve repair
#361Methods of treating cancer of the central nervous system
#362Controlled release multidrug formulations for spinal cord injury
#363Materials and methods for prevention and treatment of RNA viral diseases
#364Bacteriophage-containing therapeutic agents
#365Compositions and methods of using chondroitinase ABCI mutants
#366ENZYME PRODRUG CANCER THERAPY SELECTIVELY TARGETED TO TUMOR CELLS OR TUMOR VASCULATURE AND METHODS OF PRODUCTION AND USE THEREOF
#367Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes
#368Methods for increasing protein polyethylene glycol (PEG) conjugation
#369Pharmaceutical and/or cosmetic composition containing active-principle activators of aconitase
#370Cosmetic treatment system and methods
#371COMPOSITIONS OF PROKARYOTIC PHENYLALANINE AMMONIA-LYASE AND METHODS OF TREATING CANCER USING COMPOSITIONS THEREOF
#372Method of treating or retarding the development of blindness
#373Oncolytic virus
#374Materials and Method for Promotion of Nerve Regeneration
#375USE OF PLP WITH PEG-rMETase IN VIVO FOR ENHANCED EFFICACY
#376Compositions and methods of using chondroitinase ABCI mutants
#377Use of islet glucose-6-phosphatase related protein as a diagnostic tool and therapeutic target for autoimmune diabetes
#378Glutamic acid decarboxylase (GAD) based delivery system
#379Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging, disorders of aging, cancer, as growth factors, and as an alternative to stem cell therapy
#380Methods of treating Parkinson's disease using viral vectors
#381Cosmetic Methods And Compositions For Repairing Human Skin
#382Alginate and alginate lyase compositions and methods of use
#383CONJUGATE FOR THE SPECIFIC TARGETING OF ANTICANCER AGENTS TO TUMOR CELLS OR TUMOR VASCULATURE AND PRODUCTION THEREOF
#384Cancer selective auxotrophs
#385Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
#386IMMUNOMODULATION FOR AUTOIMMUNE TYPE-2 DIABETES
#387Glutamic acid decarboxylase (GAD) chimera and methods of use
#388PHARMACEUTICAL COMPOSITION FOR TREATING DEPRESSION AND METHOD FOR PREPARATION THEREOF
#389AGENTS FOR IMPROVING CHRONIC OBSTRUCTIVE PULMONARY DISEASES
#390AMELIORATING AGENT FOR BRAIN DAMAGE
#391Compositions and methods of using chondroitinase ABCI mutants
#392Modified heparinase III and methods of sequencing therewith
#393Method of Treating or Retarding the Development of Blindness
#394Compositions and methods of using chondroitinase ABCI mutants
#395AGENTS FOR SUPPRESSING HEPATIC FIBROSIS
#396COSMETIC METHODS AND COMPOSITIONS FOR REPAIRING HUMAN SKIN
#397Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
#398Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
#399Proteoglycan degrading mutants for the treatment of CNS
#400Fusion proteins for the treatment of CNS
#401Methods and Compositions for Reducing Oxalate Concentrations
#402Material and Methods for Nerve Grafting
#403Use of Arginase in Combination with 5FU and Other Compounds for Treatment of Human Malignancies
#404Anti-T Cell and Autoantigen Treatment of Autoimmune Disease
#405Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes
#406Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
#407Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
#408Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes
#409Materials and Methods for Prevention and Treatment of RNA Viral Diseases
#410Materials and methods for treating or preventing oxalate-related disease
#411Methods for increasing protein polyethylene glycol (PEG) conjugation
#412Method for promoting axonal re-growth and behavior recovery in spinal cord injury
#413Composition for Prevention, Treatment, and Diagnosis of Chronic Inflammatory Airway Diseases
#414METHODS AND COMPOSITIONS FOR TREATING ERECTILE DYSFUNCTION
#415Compositions and methods for the treatment and repair of defects or lesions in articular cartilage using synovial-derived tissue or cells
#416COMPOSITION FOR ATTENUATING NEUROPATHIC PAIN COMPRISING A RECOMBINANT VENTOR EXPRESSING GAD65
#417Compositions and methods for the treatment and repair of defects or lesions in articular cartilage using synovial-derived tissue or cells
#418Compositions and methods for the treatment and repair of defects or lesions in articular cartilage using synovial-derived tissue or cells
#419Crystallized oxalate decarboxylase and methods of use
#420Powdered Compositions Of Sensitive Active Materials In An At Least Partially Amorphous State
#421Compositions and methods for the treatment of CNS injuries
#422METHODS AND COMPOSITIONS FOR TREATING ERECTILE DYSFUNCTION
#423Compositions and methods for promoting neuronal outgrowth
#424Cosmetic treatment system and methods
#425Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growth factors of stem cells
#426Conjugate for the specific targeting of anticancer agents to tumor cells or tumor vasculature and production thereof
#427Targeted Drug-Formaldehyde Conjugates And Methods Of Making And Using The Same
#428Acellular bioabsorbable tissue regeneration matrices
#429Bacteriophage-containing therapeutic agents
#430Compositions and methods for oxalate reduction
#431Adept or gdept producing acetaldehyde
#432Nanosphere/microsphere delivery system for the treatment of spinal cord injury
#433Compositions and methods of using chondroitinase ABCI mutants
#434Matrices for drug delivery and methods for making and using the same
#435Composition and method of treating mastitis
#436Method of treating or retarding the development of blindness
#437Compositions and methods for enhancing axon regeneration
#438Method for preventing or delaying the onset of diabetes
#439Use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl
#440Methods for dissolving cystine stones and reducing cystine in urine
#441Glutamic acid decarboxylase (GAD) chimera and methods of use
#442Proteoglycan degrading mutants for the treatment of CNS
#443Compositions of low molecular weight heparin produced with modified heparinase III
#444Methods for preparing low molecular weight heparin with modified heparinase III
#445Use of heparinases to decrease inflammatory response
#446Bacteriophage for the treatment of bacterial biofilms
#447Alginases, systems containing alginases and methods of cloning, purifying and/or utilizing alginases
#448Compositions for treating cystic fibrosis
#449Methods and compositions for preventing the onset of type 1 diabetes
#450Glutamic acid decarboxylase (GAD) based delivery system
#451Heparinase III and methods of specifically cleaving therewith
#452Methods and compositions related to the modulation of intercellular junctions
#453Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
#454Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes
#455Method for promoting axonal outgrowth in damaged nerves
#456Methods for increasing protein polyethylene glycol (PEG) conjugation
#457Heparinase III HLGAG fragments and uses thereof
#458Materials and methods for treating or preventing oxalate-related disease
#459Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes
#460Use of heparinase to decrease inflammatory responses
#461Method of delaying the onset of diabetes
#462Methods of treating parkinson's disease using viral vectors
#463Systemic delivery of serum stable plasmid lipid particles for cancer therapy
#464Treatment of central nervous system damage
#465Method and composition for treating cancer by converting soluble radioactive toxic agents into insoluble radioactive toxic precipitates via the action of non-mammalian enzymes bound to the non-endocytosing receptors of target cells
#466Expression of membrane proteins using an adenylyl cyclase of mycobacterium tube rculosis
#467USE OF PLP WITH PEG-rMETase IN VIVO FOR ENHANCED EFFICACY
#468Lyase treatment for
#469Glutamic acid decarboxylase (GAD) based delivery systems
#470Bacterial methionine analogue and methionine synthesis inhibitor anticancer, antiinfective and coronary heart disease protective microcins and methods of treatment therewith
#471Cloned glutamic acid decarboxylase